Chlorthalidone has been shown to be more effective at lowering blood pressure than hydrochlorothiazide, especially at night, due to its longer half-life. Evidence from large clinical trials also indicates that chlorthalidone reduces cardiovascular outcomes more than hydrochlorothiazide when used for hypertension. As a result, clinical guidelines now recommend chlorthalidone as the first-line thiazide-type diuretic for treating hypertension.